Medical Devices Hong Kong

Hong Kong Body Composition Analyzers Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Hong Kong Body Composition Analyzers Market Industry Trends and Forecast to 2034: Segmented by (Technology, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Hong Kong · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.4 Mn Placeholder estimate
Estimate 2025 $1.6 Mn 0.1% of the global market
Projected 2034 $3.5 Mn 122.6% Adds $1.9 Mn over 9 forecast years
CAGR 2025–2034 9.3% Faster than 47% of 173 Medical Devices markets here
Key players 6 +1
  • Hong Kong is 0.15% of the global market.
  • In APAC, the largest is China at $80.2 Mn.
  • Fastest growing: India at 11.1% a year.
  • Hong Kong ranks 8th of 10 by size in APAC.

Market size projection

Hong Kong

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Body Composition Analyzers Market market size by year, Hong Kong
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.4 Mn — —
2025 (base) $1.6 Mn +$0.1 Mn —
2026 (forecast) $1.7 Mn +$0.1 Mn +9.3%
2027 (forecast) $1.9 Mn +$0.2 Mn +19.5%
2028 (forecast) $2.0 Mn +$0.2 Mn +30.6%
2029 (forecast) $2.2 Mn +$0.2 Mn +42.7%
2030 (forecast) $2.4 Mn +$0.2 Mn +56%
2031 (forecast) $2.6 Mn +$0.2 Mn +70.5%
2032 (forecast) $2.9 Mn +$0.2 Mn +86.4%
2033 (forecast) $3.2 Mn +$0.3 Mn +103.7%
2034 (forecast) $3.5 Mn +$0.3 Mn +122.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Hong Kong Body Composition Analyzers Market Analysis at a glance
Market size, 2025$1.6 Mn placeholder estimate
Forecast, 2034$3.5 Mn placeholder estimate
Growth (CAGR), 2025–20349.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTechnology, product and end user (see all)
Key playersInBody, Tanita, Omron Healthcare, Withings, Seca and 1 more (see all)
Regulator in Hong KongMDACSSource: Medical Device Division, Department of Health. Checked 14 Nov 2026.
Active clinical trials2 in Hong KongSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Hong Kong Body Composition Analyzers Market Analysis Executive Summary

Body composition analyzers measure fat, muscle and water in the body, used in clinics, gyms and homes to track health and weight-loss progress.

Key segments of the body Composition Analyzers market include technology (Bioelectrical Impedance, DEXA and Air Displacement) and product (Professional Analyzers and Smart Scales).

Bar chart: Hong Kong Body Composition Analyzers market size, 2024–2034, placeholder estimates. $1.4 Mn in 2024, $1.6 Mn in 2025 and $3.5 Mn in 2034, 9.3% CAGR.
Hong Kong Body Composition Analyzers market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Hong Kong Body Composition Analyzers Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the body Composition Analyzers market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the body Composition Analyzers market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the body Composition Analyzers market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Body Composition Analyzers Market in Hong Kong

The body Composition Analyzers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Body Composition Analyzers Market in Hong Kong

Body Composition Analyzers in Hong Kong: rules, payment and research

Hong Kong has a voluntary listing system for medical devices (MDACS), run by the Medical Device Division of the Department of Health.⁠[1] Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government.⁠[2] ClinicalTrials.gov lists 2 studies on Body Composition Analyzers that are recruiting, active or about to start in Hong Kong.⁠[3]

[1] Medical Device Division, Department of Health. Checked 14 Nov 2026.

[2] Hospital Authority. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how body Composition Analyzers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Hong Kong.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Body Composition Analyzers right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Body Composition Analyzers in context

Hong Kong compared

  • People aged 65 and over: 23.7% of people (2025). World: 10.4% of people (2025). 2nd highest of the 16 countries we cover in APAC.[1]

[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Body Composition Analyzers market in Hong Kong?
Placeholder estimate: about $1.6 Mn in 2025, rising to about $3.5 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Body Composition Analyzers market in Hong Kong growing?
Placeholder estimate: about 9.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Body Composition Analyzers market report cover?
The report splits the market by technology (Bioelectrical Impedance, DEXA, Air Displacement, Skinfold Calipers), product (Professional Analyzers, Smart Scales) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Body Composition Analyzers market?
Key players include InBody, Tanita, Omron Healthcare, Withings, Seca and GE Healthcare.
What is driving the Body Composition Analyzers market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the body Composition Analyzers market.
Who regulates Body Composition Analyzers in Hong Kong?
Hong Kong has a voluntary listing system for medical devices (MDACS), run by the Medical Device Division of the Department of Health. Source: Medical Device Division, Department of Health. Checked 14 Nov 2026.
How is healthcare paid for in Hong Kong?
Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government. Source: Hospital Authority. Checked 14 Nov 2026.
How many clinical trials on Body Composition Analyzers are running in Hong Kong?
2 studies are recruiting, active or about to start in Hong Kong, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 12 Nov 2026.
How much research is published on Body Composition Analyzers?
PubMed lists 8 papers on Body Composition Analyzers added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Hong Kong

See all

Related on obesity and fitness

See the topic